Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2022 Oct;92(4):631-636.
doi: 10.1002/ana.26454. Epub 2022 Aug 4.

Gut Microbiota in Monozygotic Twins Discordant for Parkinson's Disease

Affiliations

Gut Microbiota in Monozygotic Twins Discordant for Parkinson's Disease

Carlotta Bolliri et al. Ann Neurol. 2022 Oct.

Abstract

Differences in gut microbiota between Parkinson's disease patients and controls seem to depend on multiple-frequently unmeasured-confounders. Monozygotic twins offer a unique model for controlling several factors responsible for interpersonal variation in gut microbiota. Fecal samples from 20 monozygotic twin pairs (n = 40) discordant for Parkinson's disease were studied (metagenomic shotgun analysis). Paired data analysis detected minimal differences in bacterial taxa abundance at species level (Bacteroides pectinophilus [p = 0.037], Bifidobacterium pseudocatenulatum [p = 0.050], and Bifidobacterium catenulatum [p = 0.025]) and in predicted metabolic pathways (primary bile acid biosynthesis [p = 0.037]). Additional studies are warranted to understand the role of gut microbiota in the pathogenesis of Parkinson's disease. ANN NEUROL 2022;92:631-636.

PubMed Disclaimer

References

    1. Keshavarzian A, Engen P, Bonvegna S, Cilia R. The gut microbiome in Parkinson's disease: a culprit or a bystander? Prog Brain Res 2020;252:357-450. https://doi.org/10.1016/bs.pbr.2020.01.004.
    1. Cilia R, Piatti M, Cereda E, et al. Does gut microbiota influence the course of Parkinson's disease? A 3-year prospective exploratory study in de novo patients. J Parkinsons Dis 2021;11:159-170.
    1. Barichella M, Severgnini M, Cilia R, et al. Unraveling gut microbiota in Parkinson's disease and atypical parkinsonism. Mov Disord 2019;34:396-405.
    1. Goldman SM, Kamel F, Ross GW, et al. Peptidoglycan recognition protein genes and risk of Parkinson's disease. Mov Disord 2014;29:1171-1180.
    1. Hughes AJ, Ben-Shlomo Y, Daniel SE, Lees AJ. What features improve the accuracy of clinical diagnosis in Parkinson's disease: a clinicopathologic study. Neurology 2001;57:S34-S38.

Publication types

Substances

LinkOut - more resources